BioMarin Pharmaceutical Inc

NAS:BMRNHealthcareNASDAQ:NBISTOXX:EDD24BP

$54.67−0.02%At closeAt close · Tue 20 Oct · ≈ AED 200.78 · Market cap $10.58B · Next earnings Mon 26 Oct · Extended $55.12 +0.82%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	71.8%	74.5%	76.0%	78.0%	79.7%	77.1%	—	—
Operating margin	−2.3%	−4.5%	7.7%	7.7%	17.0%	16.6%	16.6%	+0.0 pts
Net margin	45.9%	−3.5%	6.8%	6.9%	15.0%	10.8%	10.8%	+0.0 pts
EBITDA margin	4.5%	2.6%	12.7%	12.7%	22.8%	17.8%	—	—
Return on equity	20.8%	−1.5%	3.1%	3.4%	7.5%	5.7%	5.7%	+0.0 pts
Return on assets	14.6%	−1.1%	2.2%	2.5%	6.1%	4.6%	4.6%	+0.0 pts
Return on capital employed	−0.8%	−1.5%	2.8%	3.3%	7.6%	7.8%	—	—
Debt / equity	0.3×	0.3×	0.2×	0.2×	0.1×	0.1×	0.1×	+0.0%
Debt / assets	18.6%	18.1%	17.2%	16.0%	9.3%	8.5%	—	—
Interest coverage	−1.5×	−5.4×	10.1×	10.7×	38.2×	48.9×	—	—
Current ratio	4.8×	4.2×	4.7×	2.5×	5.3×	5.2×	5.2×	+0.0%
Quick ratio	3.3×	2.7×	3.2×	1.6×	3.3×	3.5×	—	—
Cash ratio	1.3×	1.1×	1.2×	0.6×	1.6×	1.7×	1.7×	+0.0%
Asset turnover	0.3×	0.3×	0.3×	0.4×	0.4×	0.4×	—	—
Inventory turnover	0.8×	0.6×	0.6×	0.5×	0.5×	0.6×	—	—
Receivables turnover	4.1×	4.9×	4.5×	3.8×	4.3×	3.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—